Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E T Phillips

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Peptides|November 1, 1988
Substance P antagonist-induced spinal cord vasoconstriction: effects of thyrotropin-releasing hormone and substance P agonistsC J Helke, E T Phillips
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1988
Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenalsC J Helke, E T Phillips
Journal of the Autonomic Nervous System|February 1, 1993
Hypotensive effects of 5-HT1A receptor activation: ventral medullary sites and mechanisms of action in the ratC J Helke, C H McDonald, E T Phillips
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Intrathecal administration of a substance P receptor antagonist: studies on peripheral and central nervous system hemodynamics and on specificity of actionC J Helke, E T Phillips, J T O'Neill
Journal of the Autonomic Nervous System|November 1, 1987
Regional peripheral and CNS hemodynamic effects of intrathecal administration of a substance P receptor agonistC J Helke, E T Phillips, J T O'Neill
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1991
5-Hydroxytryptamine1C/2 agonists in the thoracic spinal cord: cardiovascular effects and binding sites in the intermediolateral cell columnC J Helke, K B Thor, E T Phillips
Neuroscience|May 1, 1995
Inhibition of axoplasmic transport in the rat vagus nerve alters the numbers of neuropeptide and tyrosine hydroxylase messenger RNA-containing and immunoreactive visceral afferent neurons of the nodose ganglionH Zhuo, A C Lewin, E T Phillips, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Peptides|November 1, 1988
Substance P antagonist-induced spinal cord vasoconstriction: effects of thyrotropin-releasing hormone and substance P agonistsC J Helke, E T Phillips
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1988
Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenalsC J Helke, E T Phillips
Journal of the Autonomic Nervous System|February 1, 1993
Hypotensive effects of 5-HT1A receptor activation: ventral medullary sites and mechanisms of action in the ratC J Helke, C H McDonald, E T Phillips
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Intrathecal administration of a substance P receptor antagonist: studies on peripheral and central nervous system hemodynamics and on specificity of actionC J Helke, E T Phillips, J T O'Neill
Journal of the Autonomic Nervous System|November 1, 1987
Regional peripheral and CNS hemodynamic effects of intrathecal administration of a substance P receptor agonistC J Helke, E T Phillips, J T O'Neill
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1991
5-Hydroxytryptamine1C/2 agonists in the thoracic spinal cord: cardiovascular effects and binding sites in the intermediolateral cell columnC J Helke, K B Thor, E T Phillips
Neuroscience|May 1, 1995
Inhibition of axoplasmic transport in the rat vagus nerve alters the numbers of neuropeptide and tyrosine hydroxylase messenger RNA-containing and immunoreactive visceral afferent neurons of the nodose ganglionH Zhuo, A C Lewin, E T Phillips, et al.
Pageof 1